Survey of Ophthalmology
Volume 49, Issue 2 , Pages 266-267 , March 2004

Foggy visual field defect

References 

  1. Biton V, Montouris GD, Ritter F, et al.  A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology. 1999;52:1330–1337
  2. Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain. 2003;19:59–68
  3. McElroy SL, Arnold LM, Shapira NA, et al.  Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003;160:225–261
  4. Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119:1721–1723
  5. Sachdeo RC, Glauser TA, Ritter F, et al.  A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology. 1999;52:1882–1887
  6. Sankar PS, Pasquale LR, Grosskreutz . Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001;119:1210–1211
  7. Sen HA, O'Halloran HS, Lee WB. Topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119:775–777
  8. Sharief M, Viteri C, Ben-Menachem E, et al.  Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 1996;25:217–224
  9. Smathers SA, Wilson JG, Nigro MA. Topiramate effectiveness in Prader-Willi syndrome. Pediatric Neurology. 2003;28:130–133
  10. Suppes T. Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol. 2002;22:599–609
  11. Thompson PJ, Baxendale SA, Duncan JS, Sander JWAS. Effects of topiramate on cognitive function. J Neurol Neurosurg Psych. 2000;69:636–641
  12. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia. 1997;41(suppl 1):S17–S20
  13. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia. 2002;22:659–663

☆ This research was supported by National Institutes of Health grant R21-EY14071, the EyeSight Foundation of Alabama, and Research to Prevent Blindness, Inc.

PII: S0039-6257(03)00178-4

doi: 10.1016/j.survophthal.2003.12.004

Survey of Ophthalmology
Volume 49, Issue 2 , Pages 266-267 , March 2004

Article Tools

* Image Usage & Resolution